This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/4F-EPH: Difference between revisions
Jump to navigation
Jump to search
>Kaylee m Text replacement - "_Afterglow=" to "_Aftereffects=" |
>Oskykins No edit summary |
||
| Line 52: | Line 52: | ||
|OralROA_Bioavailability= | |OralROA_Bioavailability= | ||
|OralROA_Threshold= | |OralROA_Threshold= | ||
|OralROA_Light= | |OralROA_Light=[[Oral min light dose::5]] - [[Oral max light dose::10]] mg | ||
|OralROA_Common=[[Oral min common dose:: | |OralROA_Common=[[Oral min common dose::10]] - [[Oral max common dose::30]] mg | ||
|OralROA_Strong= | |OralROA_Strong= | ||
|OralROA_Heavy= | |OralROA_Heavy= | ||
Revision as of 00:49, 19 June 2016
| SubstanceBox/4F-EPH | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
|||||||||||||||||
| Chemical Nomenclature | |||||||||||||||||
| Common names | 4F-EPH | ||||||||||||||||
| Systematic name | Methyl 2-(4-fluorophenyl)-2-(piperidin-2-yl)acetate | ||||||||||||||||
| Routes of Administration | |||||||||||||||||
|
|||||||||||||||||